Non-sleepy obstructive sleep apnoea: to treat or not to treat?

Non-sleepy obstructive sleep apnoea (OSA) is thought to have a prevalence of around 20-25% in industrialised countries. However, the question of whether it should be routinely treated or not is controversial. This review collates the results from recent randomised controlled trials addressing OSA an...

Full description

Saved in:
Bibliographic Details
Published in:European respiratory review 2019-12, Vol.28 (154), p.190031
Main Authors: Altintas, Nejat, Riha, Renata L
Format: Article
Language:English
Subjects:
Aged
Clinical Decision-Making
Continuous Positive Airway Pressure - methods
Female
Humans
Incidence
Male
Middle Aged
Polysomnography - methods
Prognosis
Quality of Life
Randomized Controlled Trials as Topic
Risk Assessment
Series
Severity of Illness Index
Sleep Apnea, Obstructive - diagnosis
Sleep Apnea, Obstructive - epidemiology
Sleep Apnea, Obstructive - therapy
Treatment Outcome
Watchful Waiting
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Non-sleepy obstructive sleep apnoea (OSA) is thought to have a prevalence of around 20-25% in industrialised countries. However, the question of whether it should be routinely treated or not is controversial. This review collates the results from recent randomised controlled trials addressing OSA and examines whether treating the condition leads to improvements in quality of life and reduced cardiometabolic dysfunction, comorbidities generally attributed to untreated obstructive sleep apnoea/hypopnoea syndrome.
ISSN:0905-9180
1600-0617
DOI:10.1183/16000617.0031-2019